Predictors of lost to follow up from antiretroviral therapy among adults in sub-Saharan Africa: a systematic review and meta-analysis.
Hafte Kahsay KebedeLillian MwanriPaul WardHailay Abrha GesesewPublished in: Infectious diseases of poverty (2021)
The current review identifies demographic, behavioral and clinical factors to be determinants of LTFU. We recommend strengthening of HIV care services in SSA targeting the aforementioned group of patients. Trial registration Protocol: the PROSPERO Registration Number is CRD42018114418.
Keyphrases
- antiretroviral therapy
- end stage renal disease
- ejection fraction
- randomized controlled trial
- newly diagnosed
- hiv infected
- clinical trial
- primary care
- study protocol
- peritoneal dialysis
- human immunodeficiency virus
- hiv aids
- hiv infected patients
- dna methylation
- hiv positive
- patient reported outcomes
- open label
- men who have sex with men
- placebo controlled